In the study, alcohol-dependent rats were treated with semaglutide, which significantly reduced their alcohol consumption and even reduced the drinking of alcohol in conjunction with relapses
Patients on tirzepatide were twice as likely to lose at least 25% of their body weight, and nearly one in five (19.7%) lost 30% or more, compared to fewer than one in fourteen (6.9%) on semaglutide.[1] Both medications also improved blood pressure, blood sugar, and cholesterol levels, with greater improvements seen in the tirzepatide group, which tracked with the larger weight reduction.[1] The safety profiles were similar
Preliminary results indicate that while some posts emphasize the ecological importance of bats, others highlight concerns related to biosafety, zoonotic disease risks, and institutional transparency
Am J Obstet Gynecol
By week 52, the rate of menstrual complaints in tirzepatide patients approaches the placebo rate, suggesting adaptation
Week 12 to 16: Peak results from the cycle